Vyome Holdings (HIND) Income from Non-Controlling Interests (2025 - 2026)
Vyome Holdings (HIND) posted quarterly Income from Non-Controlling Interests of -$22611.0 for Q1 2026, up 58.3% quarter-over-quarter from -$54217.0 in Q4 2025.
Vyome Holdings (HIND) Income from Non-Controlling Interests (2025 - 2026) Analysis & Trends
Vyome Holdings' Income from Non-Controlling Interests history runs 2 years deep, the most recent figure standing at -$22611.0 for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 63.60 Mn |
| 10 | Vyome Holdings | 16.07 Mn | 8.18 Mn | 11,658.00 | -34,127.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -34,127.00 |
| Mar 31, 2026 | -22,611.00 |
| Dec 31, 2025 | -54,217.00 |
| Sep 30, 2025 | -161,489.00 |